scholarly journals SARS-CoV-2 - Understanding for the Preparation of Forthcoming Corona Virus Outbursts

2020 ◽  
pp. 46-55

A new major epidemic foci of corona virus disease 2019 known as COVID-19, previously known as 2019-nCoV have been identified and rapidly expanding throughout the world without traceable origin since early 2020. The disease has drastically increased and the affected number of countries, states or territories reporting infection to WHO was more than 2001. The 2019 novel corona virus disease outbreak was instigated from Wuhan, Hubei province, China at late December 2019 and affirmed as a public health threat emerging of International anxiety on 30th January 2020 by WHO2. International Committee on Taxonomy of Viruses (ICTV) declared “Severe Acute Respiratory Syndrome Corona Virus (SARS-CoV2)” as the name of novel corona virus, because their genetically similarities with SARS outbreak in 2003. The present review focuses on morphological, genetical characterization of SARS – CoV – 2 as well as the clinical traits and clinical therapies for COVID – 19 endemic up to date. The novel coronavirus emergence awaken the echoes of SARS-CoV pandemic in past decades. Yet, with having best technological advance, the exact medication is still a question. It might be a great lesson to the world to equip to deal with most recent emergent viruses in future. The current work will give a deep understanding of CoV -2 to researcher for the further studies.

Author(s):  
Р.А. Майер ◽  
Б.А. Бакиров ◽  
А.А. Набиева ◽  
Д.А. Кудлай

Введение. В последние 2 года серьезной проблемой для всего мирового сообщества стало распространение новой коронавирусной (CoV) инфекции COVID-19 (COrona VIrus Disease-2019). Ввиду сложившихся событий в лечении COVID-19 активно стали применяться новые молекулы и уже зарегистрированные лекарственные препараты, доказавшие свою эффективность при других заболеваниях. Цель исследования: оценить эффективность применения препарата экулизумаб у пациентов с тяжелой формой течения COVID-19. Материалы и методы. Проанализированы 3 клинических случая применения препарата экулизумаб в составе комплексной терапии у пациентов с тяжелой формой течения COVID-19. Для оценки эффективности лечения проводился мониторинг основных клинико-лабораторных показателей, а также показателей, характеризующих воспалительный процесс при коронавирусной инфекции: общий анализ крови, биохимический анализ крови, проанализированы уровни таких показателей как ферритин, С-реактивный белок, интерлейкин-6, лактатдегидрогеназа и мембраноатакующий комплекс. Результаты. На фоне проводимой терапии выявлено снижение концентрации основных маркеров воспаления относительно исходных значений. Заключение. Комплексная терапия, включающая экулизумаб, облегчает течение заболевания, позволяет сократить длительность пребывания пациентов в отделении реанимации и интенсивной терапии, укорачивает срок их пребывания на искусственной вентиляции легких, тем самым снижая процент летальности. Background. In the past two years, the incidence of the novel coronavirus (CoV) infection COVID-19 (COrona Virus Disease-2019) has been a serious problem for the global community. Considering these circumstances, new molecules and already registered drugs that have proven their effectiveness in other diseases, began to be actively used in COVID-19 treatment. Objectives: to assess the effi cacy of eculizumab in patients with severe COVID-19. Patients/Methods. Three clinical cases of eculizumab use as a part of complex therapy in patients with severe COVID-19 have been analyzed. To assess the treatment efficacy, the main clinical and laboratory parameters and indicators of inflammatory process in coronavirus infection were monitored (clinical blood analysis, biochemical blood test, levels of ferritin, C-reactive protein, interleukin-6, lactate dehydrogenase and membrane attack complex). Results. Under the therapy we found the reduction of concentration of the main inflammation markers relative to the initial values. Conclusions. Complex therapy with eculizumab facilitates the course of the disease, reduces the stay duration of patients in the intensive care unit, shortens the period of artificial lung ventilation, thereby reducing the mortality rate.


2020 ◽  
Vol 11 (SPL1) ◽  
pp. 1689-1694
Author(s):  
Amir Ali

After the hike of the Coronavirus from the country of China in the end of the previous year, Novel Coronavirus accounts for a total of about 46 million cases all around the world with the death of more than 1.28 million individuals & 31.8 million recoveries. Besides its extraordinary infectivity & casualty rates, Corona Virus Disease has caused widespread panic, economic weight & budgetary misfortunes. Mass terror of CORONA VIRUS, named as "corona phobia", has made an adequate mental indications in over-all population. Along these lines, this audit has been embraced to characterize panic consequence of CORONA Virus. The quarantine can create extreme anger, nervousness, accumulating, psychological illness & sadness. Strengthened through an "infodemic" extent through a various foundation in web-based broadcasting. Upheavals bigotry, defamation, & tolerance against specific networks remain additionally being broadly detailed. All things considered, bleeding-edge medical services laborers are at higher danger of getting the illness just as encountering unfriendly mental results in a type of burnout, tension, fear of communicating contamination, a sentiment of contrariness, wretchedness, & extended substance-reliance. Network-based alleviation projects to battle coronavirus will upset youngster normal way of life & may cause flowery psychological depression. Networks remain pretentious by disease in several manners & want exceptional consideration. 


Author(s):  
Sangeeta Singh

Corona Virus Disease-2019 commonly known as COVID-19 which has been defined by the Novel Corona Virus. It is a family of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) and was first detected during respiratory outbreak. It was first reported to the World Health Organization on December 31, 2019. On January 30, 2020, the World Health Organization declared the COVID-19 eruption a global health emergency. As of 27-May-2021 169,095,283 confirmed cases have been reported in the world and 2, 73, 67, 935 cases in India. It is required to identify the infection with high precision rate but there are lots of deficiency in the diagnosing system that may resulted false alarm rate. Initially it could be detected through throat saliva but now it can also be identified thought the impairment in lungs from computerized tomographical imaging technique. This paper reviewed various researches over COVID-19 diagnosis approach as well as the syndrome in respiratory organs. There are so many imaging techniques through which lungs impairments can be detected that may diagnose COVID-19 with high level of accuracy. CT scan image is the best alternative for diagnosing COVID-19.


Author(s):  
Daksh Hardaswani

The novel corona virus disease (COVID-19) is a pandemic due to the global health crisis it has created in the world and greatest challenges that it has introduced in this 21ST century. COVID-19 is the the 5th pandemic which was first reported in Wuhan, China and gradually spread into the other parts of the world. This virus is a spillover of an animal virus and then also adapted the ability of transferring human to human. The virus is highly contagious due to rapid spread and constantly evolves in the human population.  COVID-19 pandemic is a lot more than just a health emergency, but it is also socio-economic because people are losing jobs and income. The COVID-19 disease affects physical and mental health due to isolation. Moreover, more and more countries are affecting the cases of COVID-19 which are rising very rapidly day by day. Therefore, every country needs to several actions which accelerates their safety health, balance between the protection of health, prevent economic and social disruption due to this pandemic. In the spirit of the solidarity, we all need to be contributing our self to protect this situation. However, every country is equally responsible for determining the measures to prevent or decrease the viral transmission. Government authorizes also trying to act for reduce disease’s trajectory and they focus on develop the vaccination and therapeutic drugs.  Aim: To find causes, symptoms, awareness, Prevention, and treatment of COVID-19. Conclusion: The world is going by the critical situation and that is COVID-19 pandemic which is originated due to corona virus. Shortness of breath, fever and dry cough are most common symptoms of the novel corona virus. COVID-19 is highly contagious, so we must keep safe distance from other people and wear a mast hand wash our hands frequently. As it were together can we overcome the interwoven wellbeing and social and financial impacts of the widespread and anticipate its acceleration into an extended compassionate and nourishment security catastrophe, with the potential misfortune of as of now accomplished advancement picks up. 


2020 ◽  
Author(s):  
Stephanie Gabriele Werner ◽  
Hans-Eckhard Langer

Abstract Background: The novel coronavirus SARS‐CoV‐2 (severe acute respiratory syndrome coronavirus 2) and its associated disease COVID‐19 (Corona Virus Disease 19) has become a worldwide pandemic since its first cases in December 2019 in Wuhan Province in China. In Germany the pandemic started in February 2020.Case presentation: A 4 year old boy was presented and suffered from pain in the right hip. Arthrosonography demonstrated a significant effusion in the involved joint. The extended history revealed a slight but long lasting cold before. Serological findings were inconspicuous except for positive ELISA (Enzyme-linked Immuno Sorbent Assay) - test for SARS-CoV-2. Conclusion: In conclusion we believe that we can report the first case of reactive arthritis associated with SARS-CoV-2 in children.


2020 ◽  
Vol 90 (1) ◽  
Author(s):  
Sumita Agrawal ◽  
Akhil Dhanesh Goel ◽  
Nitesh Gupta

The Novel corona virus 2019 which started as an outbreak in China in December 2019 has rapidly spread all over the world, such that on 11th March 2020 WHO declared this disease as pandemic. The emergency that the world faces today demands that we develop urgent and effective measures to protect people at high risk of transmission. WHO has accelerated research in diagnostics, vaccines and therapeutics for this novel coronavirus.


2020 ◽  
Vol 11 (SPL1) ◽  
pp. 54-61 ◽  
Author(s):  
Madhurya Kadavakollu ◽  
Veera Venkata Satyanarayana Reddy Karri ◽  
Kuppusamy Gowthamarajan ◽  
Arun Radhakrishnan ◽  
Dhanabal Palanisamy ◽  
...  

In the mid-end of December 2019, several cases of pneumonia outbreak of unknown cause and etiology were identified in Wuhan City of Hubei province in China, a city with a population of over 11 million.Till date(April 2020) around 1,051,635 confirmed cases of coronavirus disease 2019(COVID-19) and 56,985 confirmed deaths have been reported according to COVID-19 Situation Report – 75 by WHO. On 7th January 2020, the causative agent was identified and named consequently as Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) by the Chinese Centre for Disease Control and Prevention (CCDC) from throat swab samples. Later, on 12th January 2020, this coronavirus was named as 2019-novel coronavirus (2019-nCoV) by World Health Organization (WHO) and in 11th February 2020,it has been declared the epidemic disease caused by SARS-CoV-2 as Corona Virus Disease 2019(COVID-19) as it is spreading rapidly from its origin in Wuhan City to the rest of the world. In this context, the current review provides a landscape of the novel Corona Virus including its origin, transmission, epidemiology, drugs and vaccines in clinical trials for better understanding to the reads and peoples the status and future perspectives of this pandemic disease


2020 ◽  
Vol 48 (9) ◽  
pp. 030006052094380 ◽  
Author(s):  
Ling Xue ◽  
Jiao Li ◽  
Lin Wei ◽  
Cuiqing Ma

In December 2019, a new respiratory disease manifesting as viral pneumonia emerged in Wuhan, China. Isolation and identification of the virus showed that the pathogen causing this disease was a novel coronavirus. On January 12, 2020, the World Health Organization named the novel coronavirus causing the outbreak 2019 novel coronavirus (2019-nCoV). The disease caused by the virus was named coronavirus disease 2019 (COVID-19). Later, the Coronavirus Study Group of the International Committee on Taxonomy of Viruses formally named this virus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The virus shows strong infectivity and high lethality, arousing widespread concern. As an emerging virus, a comprehensive understanding of SARS-CoV-2 is missing. To provide a reference and a theoretical basis for further study of SARS-CoV-2, recent advances in our understanding of the virus are summarized in this review.


Author(s):  
Hemant Bherwani ◽  
Ankit Gupta ◽  
Saima Anjum ◽  
Avneesh Anshul ◽  
Rakesh Kumar

Abstract The pandemic of “Corona Virus Disease 2019” or COVID-19 has taken the world by storm. Majority of nations of the world have been challenged by the novel coronavirus, which is supposedly of zoonotic origin and is known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The present work attempts to evaluate the spread of COVID-19 in India. The methodology of assessment uses SEIR (Susceptible-Exposed-Infectious-Removed) model to establish the impact of socio-behavioural aspect, especially social distancing, affecting the numbers of COVID-19 cases per day. The lockdown initiated by Government of India (GoI) scenario is weighed against a scenario with a possible initiation of community spread due to crowded gatherings in India. The resultant changes, as against the lockdown scenario, has been reported in terms of the increase in the number of cases and stretch of the timeline to mitigate the COVID-19 spread. Impact of environmental factors like temperature and relative humidity have also been analyzed using statistical methods, including Response Surface Methodology (RSM) and Correlation. It has been found that the spread of cases is dependent on environmental conditions, i.e. temperature and relative humidity. This study is expected to help the policymakers and stakeholders to device an improved action plan to alleviate the COVID-19 spread, especially in India.


Author(s):  
Daksh Hardaswani

The corona virus COVID-19 is the pandemic due to global health crisis among the world and greatest challenge that we have faced in 21ST century. The novel corona virus disease COVID-19 has become the 5th pandemic which is reported in Wuhan, China and gradually spread into worldwide. This virus is a spillover of an animal virus and then also adapted the ability of transferring human to human. This virus is highly contagious due to rapid spread and constantly evolves in the human population. This virus has spread to every continent of the world and the death ratio is staggering. The COVID-19 pandemic is a lot more than just a health calamity, but it is also socio-economic because people are losing jobs and income. The COVID-19 disease affects physical and mental health due to isolation. Moreover, more and more countries are affecting the cases of COVID-19 which are rising very rapidly day by day. Therefore, every country needs to several actions which accelerates their safety health, balance between the protection of health, prevent economic and social disruption due to this pandemic. In the spirit of the solidarity, we all need to be contributing our self to protect this situation. However, every country is equally responsible for determining the measures to prevent or decrease the viral transmission. Government authorizes also trying to act for reduce disease’s trajectory and they focus on develop the vaccination and therapeutic drugs.  


Sign in / Sign up

Export Citation Format

Share Document